Explore expert-informed guidance on the diagnosis, management, and pharmacotherapy of hereditary angioedema (HAE) in pediatric and adolescent patients.
The new Pediatric and Adolescent HAE eYardstick addresses updated disease classifications and diagnostic criteria, evidence-based approaches to individualized treatment, and the clinical indications, mechanisms of action, and efficacy data associated with established and emerging therapies.
Concise, synthesized content, tables, and clinical decision-making tools make it easy to navigate directly to the information most relevant to you. Use the eYardstick for focused learning or as a point-of-practice resource.
This activity is sponsored by an educational grant from Ionis Pharmaceuticals, Inc.
